I am a
Home I AM A Search Login

Papers of the Week

2020 Feb 27

BMC Womens Health



Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study.


Li L, Zhang R, Zeng J, Ke H, Peng X, Huang L, Zhang H, Chen Z, Li T, Tan Q, Yang Y, Li X, Li X
BMC Womens Health. 2020 Feb 27; 20(1):39.
PMID: 32106860.


To investigate the effectiveness and safety of 3 mg drospirenone and 20 μg ethinyl estradiol tablet (3 mg DRSP/20 μg EE) in the treatment of polycystic ovary syndrome (PCOS).